Renal angiomyolipoma: long-term results after arterial embolization
- PMID: 15640409
- DOI: 10.1097/01.RVI.0000143769.79774.70
Renal angiomyolipoma: long-term results after arterial embolization
Abstract
Purpose: Selective arterial embolization of renal angiomyolipomas (AMLs) was performed to prevent hemorrhage in patients with AMLs larger than 4 cm. This study was conducted to evaluate the long-term efficacy of AML embolization.
Materials and methods: Nineteen patients underwent embolization for 30 renal AMLs between July 1991 and June 2002. Of these, 10 patients had tuberous sclerosis (TS) with multiple AMLs and nine patients had a solitary sporadic AML. Embolization was performed with use of ethanol mixed with iodized oil (Ethiodol) in 29 tumors; coils were used in addition to the ethanol/Ethiodol mixture in one case. All tumors were completely embolized according to angiographic criteria including vascular stasis and absence of arterial feeders. The efficacy of embolization was determined over a mean follow-up period of 51.5 months (range, 6-132 months). Recurrence was defined as an increase in tumor size of greater than 2 cm on follow-up imaging and/or recurrent symptoms that required repeat embolization. An institutional review board exemption was obtained to perform this retrospective study.
Results: Embolization of the renal AMLs was technically successful in all 19 patients and for all 30 lesions. AML recurrence was noted in 31.6% of patients (n = 19) and for 30% of lesions overall (n = 9). Six of 10 patients in the TS group had AML recurrences. No recurrences occurred in the patients with sporadic AML. In the TS group of 10 patients, there was a total of 21 AMLs and the overall tumor recurrence rate was 42.9% (nine of 21). Six lesions in four patients had to be reembolized because of recurrent symptoms, including one hemorrhage, and three lesions in two patients required repeat embolization because of a greater than 2 cm increase in size. The median time interval from embolization to recurrence was 78.7 months (range, 13-132 months). Statistical testing with use of the Fisher exact test demonstrated that patients with TS were significantly more likely to develop recurrence than those without TS (P = .01).
Conclusions: Transarterial embolization is effective in preventing hemorrhage in patients with renal AMLs. However, long-term follow-up revealed a high AML recurrence rate in patients with TS. Lifelong surveillance for recurrence after AML embolization is essential in patients with TS.
Comment in
-
Re: Renal angiomyolipoma--long-term results after arterial embolization.J Vasc Interv Radiol. 2005 Aug;16(8):1153-4; author reply 1154. doi: 10.1097/01.RVI.0000167865.84963.FE. J Vasc Interv Radiol. 2005. PMID: 16105930 No abstract available.
Similar articles
-
Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex.Am J Kidney Dis. 2006 Jan;47(1):95-102. doi: 10.1053/j.ajkd.2005.09.028. Am J Kidney Dis. 2006. PMID: 16377390
-
[Spontaneous rupture of renal angiomyolipoma with tuberous sclerosis during long-term follow-up: a case report].Hinyokika Kiyo. 2001 Sep;47(9):645-8. Hinyokika Kiyo. 2001. PMID: 11692603 Japanese.
-
Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated.BJU Int. 2010 Jan;105(1):101-6. doi: 10.1111/j.1464-410X.2009.08649.x. Epub 2009 Jun 2. BJU Int. 2010. PMID: 19493268
-
Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.Asian J Surg. 2020 Oct;43(10):967-972. doi: 10.1016/j.asjsur.2019.12.008. Epub 2020 Jan 17. Asian J Surg. 2020. PMID: 31959574 Review.
-
The radiological diagnosis and treatment of renal angiomyolipoma-current status.Clin Radiol. 2010 Feb;65(2):99-108. doi: 10.1016/j.crad.2009.09.014. Epub 2009 Dec 3. Clin Radiol. 2010. PMID: 20103431 Review.
Cited by
-
Wunderlich Syndrome: A Seldom Presentation of a Relatively Ubiquitous Tumor.Cureus. 2024 Mar 13;16(3):e56126. doi: 10.7759/cureus.56126. eCollection 2024 Mar. Cureus. 2024. PMID: 38618421 Free PMC article.
-
[Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma].Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):326-331. doi: 10.19723/j.issn.1671-167X.2024.02.020. Beijing Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38595253 Free PMC article. Chinese.
-
Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH).J Clin Med. 2023 May 10;12(10):3385. doi: 10.3390/jcm12103385. J Clin Med. 2023. PMID: 37240490 Free PMC article.
-
Long-term volume reduction in renal angiomyolipomas embolized by gelatin sponge particles with or without supplementary microcoil embolization.J Int Med Res. 2023 Apr;51(4):3000605231170098. doi: 10.1177/03000605231170098. J Int Med Res. 2023. PMID: 37115168 Free PMC article.
-
Selective arterial embolization of renal angiomyolipoma: comparing ethanol-lipiodol emulsion and polyvinyl alcohol particles as embolic agents.Diagn Interv Radiol. 2023 Jan 31;29(1):170-174. doi: 10.5152/dir.2022.21625. Epub 2022 Dec 7. Diagn Interv Radiol. 2023. PMID: 36960593 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical